Please enter company name or stock symbol

Advanced Search

Hikma Pharmaceuticals(HIK)

Up
Share Price:
2,570.00p
Change Today:
29.00p
Market Cap:
£5,924m
Sector:
Pharmaceuticals & Biotechnology

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

HIK Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 1,440.00 318.00 143.70¢ 20.3 n/a -5% 32.00¢ 1.1%
31-Dec-16 1,950.00 210.00 118.50¢ 20.3 n/a -18% 33.00¢ 1.4%
31-Dec-17 1,936.00 (738.00) 105.00¢ 13.7 n/a -11% 34.00¢ 2.4%
31-Dec-18 2,070.00 293.00 137.80¢ 15.8 0.5 +31% 38.00¢ 1.7%
31-Dec-19 2,207.00 491.00 150.40¢ 16.8 1.9 +9% 44.00¢ 1.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

 

HIK Market Data

Currency UK Pounds
Share Price 2,570.00p Price Up
Change Today +29.00p
52 Week High 2,673.00p
52 Week Low 1,701.50p
Volume 231,642
Shares Issued 230.50m
Market Cap £5,924m

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.